- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.50 Å
- Oligo State
- homo-trimer
- Ligands
- 6 x ZN: ZINC ION(Non-covalent)
- 15 x SO4: SULFATE ION(Non-functional Binders)
SO4.3: 7 residues within 4Å:- Chain A: R.82, R.130, H.142
- Chain B: F.44, E.45, N.46, M.47
7 PLIP interactions:4 interactions with chain B, 3 interactions with chain A- Hydrogen bonds: B:E.45, B:N.46, B:N.46, B:M.47
- Salt bridges: A:R.82, A:R.130, A:H.142
SO4.4: 3 residues within 4Å:- Chain A: Y.81, R.82, R.83
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:R.83
SO4.5: 5 residues within 4Å:- Chain A: K.69, E.168, G.169, H.170, N.171
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:G.169, A:N.171
- Salt bridges: A:K.69
SO4.6: 2 residues within 4Å:- Chain A: T.111, D.112
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:D.112
SO4.7: 5 residues within 4Å:- Chain A: N.80, Q.160, S.163, I.164, L.167
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:N.80, A:Q.160, A:S.163
- Water bridges: A:S.76
SO4.11: 7 residues within 4Å:- Chain B: R.82, R.130, H.142
- Chain C: F.44, E.45, N.46, M.47
7 PLIP interactions:4 interactions with chain C, 3 interactions with chain B- Hydrogen bonds: C:E.45, C:N.46, C:N.46, C:M.47
- Salt bridges: B:R.82, B:R.130, B:H.142
SO4.12: 3 residues within 4Å:- Chain B: Y.81, R.82, R.83
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:R.83
SO4.13: 5 residues within 4Å:- Chain B: K.69, E.168, G.169, H.170, N.171
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:G.169, B:N.171
- Salt bridges: B:K.69
SO4.14: 2 residues within 4Å:- Chain B: T.111, D.112
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:D.112
SO4.15: 5 residues within 4Å:- Chain B: N.80, Q.160, S.163, I.164, L.167
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:N.80, B:Q.160, B:S.163
- Water bridges: B:S.76
SO4.19: 7 residues within 4Å:- Chain A: F.44, E.45, N.46, M.47
- Chain C: R.82, R.130, H.142
7 PLIP interactions:3 interactions with chain C, 4 interactions with chain A- Salt bridges: C:R.82, C:R.130, C:H.142
- Hydrogen bonds: A:E.45, A:N.46, A:N.46, A:M.47
SO4.20: 3 residues within 4Å:- Chain C: Y.81, R.82, R.83
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:R.83
SO4.21: 5 residues within 4Å:- Chain C: K.69, E.168, G.169, H.170, N.171
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:G.169, C:N.171
- Salt bridges: C:K.69
SO4.22: 2 residues within 4Å:- Chain C: T.111, D.112
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:D.112
SO4.23: 5 residues within 4Å:- Chain C: N.80, Q.160, S.163, I.164, L.167
4 PLIP interactions:4 interactions with chain C- Hydrogen bonds: C:N.80, C:Q.160, C:S.163
- Water bridges: C:S.76
- 3 x 2F5: 1H-BENZIMIDAZOL-2-YL(4-{[3-(MORPHOLIN-4-YL)PYRAZIN-2-YL]OXY}PHENYL)METHANONE(Non-covalent)
2F5.8: 16 residues within 4Å:- Chain A: Y.86, H.87, L.237, S.239, V.240, I.254, Y.255, F.258, P.274, M.275, K.280, E.283, V.284, G.287, Q.288, F.291
10 PLIP interactions:10 interactions with chain A- Hydrophobic interactions: A:F.258, A:P.274, A:E.283, A:V.284, A:F.291
- Hydrogen bonds: A:Y.255, A:Q.288
- Water bridges: A:M.275
- pi-Stacking: A:F.291, A:F.291
2F5.16: 16 residues within 4Å:- Chain B: Y.86, H.87, L.237, S.239, V.240, I.254, Y.255, F.258, P.274, M.275, K.280, E.283, V.284, G.287, Q.288, F.291
10 PLIP interactions:10 interactions with chain B- Hydrophobic interactions: B:F.258, B:P.274, B:E.283, B:V.284, B:F.291
- Hydrogen bonds: B:Y.255, B:Q.288
- Water bridges: B:M.275
- pi-Stacking: B:F.291, B:F.291
2F5.24: 16 residues within 4Å:- Chain C: Y.86, H.87, L.237, S.239, V.240, I.254, Y.255, F.258, P.274, M.275, K.280, E.283, V.284, G.287, Q.288, F.291
9 PLIP interactions:9 interactions with chain C- Hydrophobic interactions: C:F.258, C:P.274, C:E.283, C:V.284, C:F.291
- Hydrogen bonds: C:Q.288
- Water bridges: C:M.275
- pi-Stacking: C:F.291, C:F.291
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hu, E. et al., Design, Optimization, and Biological Evaluation of Novel Keto-Benzimidazoles as Potent and Selective Inhibitors of Phosphodiesterase 10A (PDE10A). J.Med.Chem. (2013)
- Release Date
- 2013-10-23
- Peptides
- cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
BC
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.50 Å
- Oligo State
- homo-trimer
- Ligands
- 6 x ZN: ZINC ION(Non-covalent)
- 15 x SO4: SULFATE ION(Non-functional Binders)
- 3 x 2F5: 1H-BENZIMIDAZOL-2-YL(4-{[3-(MORPHOLIN-4-YL)PYRAZIN-2-YL]OXY}PHENYL)METHANONE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hu, E. et al., Design, Optimization, and Biological Evaluation of Novel Keto-Benzimidazoles as Potent and Selective Inhibitors of Phosphodiesterase 10A (PDE10A). J.Med.Chem. (2013)
- Release Date
- 2013-10-23
- Peptides
- cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
BC
B